About Our Business| Bioxcellence | Boehringer Ingelheim About Our Business| Bioxcellence | Boehringer Ingelheim BioXcellence, reliable contract development & manufacturing partner to the pharmaceutical industry. A trusted partner through the Lifecyle of your product.
Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim Experience our exceptional expertise in upstream & downstream biopharmaceutical processing, utilizing mammalian cell cultures & microbial organisms.
Large Scale Cell Culture Facility | Bioxcellence | Boehringer Ingelheim Large Scale Cell Culture Facility | Bioxcellence | Boehringer Ingelheim Tour our Large Scale Cell Culture Facility in Vienna, Austria, advancing biopharmaceutical production with cutting-edge cell culture technology.
Excellence in innovation | Bioxcellence | Boehringer Ingelheim Excellence in innovation | Bioxcellence | Boehringer Ingelheim Discover BioXcellence's commitment to innovation in pharmaceutical production, delivering cutting-edge solutions for your biopharmaceutical needs.
Monoclonal Antibody Production | Bioxcellence | Boehringer Ingelheim Monoclonal Antibody Production | Bioxcellence | Boehringer Ingelheim Explore our advanced capabilities in antibody production, and learn about the unique features of monoclonal & polyclonal antibodies.
Whitepaper_expertise-in-microbial-technology_May2023.pdf Whitepaper_expertise-in-microbial-technology_May2023.pdf
Final_Leistungen-an-PO_2022_Nachmeldung-national-BIKG Final_Leistungen-an-PO_2022_Nachmeldung-national-BIKG
Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development
2023 Moving towards a rabies-free Southeast Asia_Whitepaper.pdf 2023 Moving towards a rabies-free Southeast Asia_Whitepaper.pdf
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate Partnering in Biotherapeutics Technologies MARCH 2023 Corporate